Boston, MA -- (SBWIRE) -- 12/16/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: OncoSec Medical Inc (OTCMKTS:ONCS ), New Energy Technologies Inc (OTCMKTS:NENE), Applied DNA Sciences Inc (OTCMKTS:APDN), Cellceutix Corp (OTCMKTS:CTIX)
OncoSec Medical Inc (OTCMKTS:ONCS ) increased 9.76% at the price of $0.371 recently on a traded volume of 4.06 million shares, in comparison to 1.24 million shares of average trading volume. So far this year, the stock is up over 68.18%.
The company has a total market capitalization of $63.21 million and its total outstanding shares are 170.84 million. OncoSec Medical Incorporated is a drug-medical device and therapeutic company. The Company is focused on designing, developing and commercializing medical approaches for the treatment of solid tumors that have unmet medical needs or where approved therapies are inadequate based on their efficacy or side-effects.
For How Long ONCS will Fight for Profitability? Read This Trend Analysis report
New Energy Technologies Inc (OTCMKTS:NENE) soared 4.78% at the trading price of $2.41 on a traded volume of 328,103.00 shares till now, whereas its average trading volume is 184,171.00 shares. In the last three months, the stock is up 12.09%. The Intra-day range for the stock is $2.36 and $2.89. New Energy Technologies, Inc. is a development-stage company. The Company is engaged in renewable and alternative energy business. The Company conducts its operations through two wholly owned subsidiaries.
For How Long NENE Gloss will Attract Investors? Find out via this report
Applied DNA Sciences Inc (OTCMKTS:APDN) jumped up 5.82% at the $0.180 recently. So far in three months, the stock is up 47.98%. The 52-week range for the stock is $0.08 and $0.31. Its introductory price for the day was $0.18, with the overall traded volume of 3.26 million shares. Applied DNA Sciences, Inc. is a provider of botanical-deoxyribonucleic acid (DNA) based security and authentication solutions that can help protect products, brands and property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Will APDN Continue To Move Higher? Find Out Here
Cellceutix Corp (OTCMKTS:CTIX) after opening its shares at the price of $1.84, jumped up 7.61% , its recent trading price was $1.98 for the day. The stock moved on a traded volume of 251,911.00 shares, in comparison to 175,029.00 shares of average trading volume.
The 52-week range for the stock is $1.40 and $2.47. Its introductory price for the day was $1.84. Cellceutix Corporation is an early-stage developmental biopharmaceutical company. The Company has acquired exclusive rights to eight different pharmaceutical compound candidates that are designed for treatment of diseases which exist, or may exist in the future.
Why Should Investors Buy CTIX After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)